About EnergyNote
Who writes EnergyNote, what it covers, and the principles behind every article.
EnergyNote is written by a South Korean author trained in nuclear engineering and radiation science. The Korean edition covers everyday radiation questions and Korea’s energy debates; this English edition focuses on what an insider’s view from Korea can add for international readers.
Who writes this
The EnergyNote editor studied nuclear engineering and radiation science and writes from South Korea. The views here are personal. Every article carries a “Data as of” date, named sources, and a separate fact check before publication.
What you will find here
- SMR and nuclear licensing, tracked by stage — design approval, construction permit, construction, commissioning — rather than by press release.
- Korea’s nuclear program — the i-SMR design review, SMART100, Korea’s new-build debate, decommissioning of Kori-1, and the Korean manufacturers inside Western SMR supply chains.
- Fukushima treated-water discharge as seen from next door — how Korea monitors its own waters and seafood, and what the numbers say three years in.
- Radiation in daily life, when there is something specific to add.
Principles
- Numbers carry their dates. Every article shows a “Data as of” date under the title, and time-sensitive figures are dated inline. When a figure is updated, the date is updated with it.
- Primary sources first. Regulators (NRC, CNSC, ONR, Korea’s NSSC and KINS), the IAEA, UNSCEAR and ICRP, peer-reviewed papers, and company filings. Where only news reporting is available, the outlet is named.
- Both sides of contested questions. New nuclear build, Fukushima discharge and low-dose radiation are argued on the merits, with the counter-arguments stated in their strongest form.
- No hype. SMRs are one of several candidate technologies, not a settled future. Company targets are reported as targets.
Disclaimers
- Health. Articles on radiation and health are general information from a radiation-protection perspective and do not replace medical diagnosis or treatment. Consult your physician for decisions about examinations or treatment.
- Industry and companies. Sections on industry structure and listed companies are for understanding the sector. They are not recommendations to buy or sell any security. The author is not a licensed investment adviser, and investment decisions are your own responsibility.
- Independence. The author does not represent any employer, agency or company. Corrections are welcome via the contact page.
The Korean edition is at energynote.kr.